GBT
Continues
Research
on
AI
Detection
System
San Diego, CA -- January 7,
2021 -- InvestorsHub NewsWire -- GBT Technologies Inc.
(OTC
PINK: GTCH)
("GBT", or the "Company"), announced that
its joint venture,
GBT
Tokenize Corp. ("GBT/Tokenize"),
is
continuing with
its research associated
with an
AI system to detect and open clogs within arteries based on its
proprietary radio
technology, which has an
internal code
name of
"Hermes".
The research is evaluating
a system
targeted for arterial clogs cleaning, such as a coronary artery,
peripheral artery, or any other body vascular organ.
The researching
is focusing
on the
use of an intravenous mini-probe unit
that could travel within the artery,
searching to find clogs including complete blockages (Total
Occlusions). Upon detecting a clog, GBT/Tokenize
will evaluate
whether the system will have the capability to
remove it and clear the blood vessel for
efficient blood flow. This blockage may cause a condition called
atherosclerosis (when a substance called
plaque builds up in the walls of the arteries) and can eventually
block the artery, causing vascular disease, heart attack or stroke.
The research is evaluating
whether the unit can use AI based and radio
frequency imaging system to "see" within arteries.
We are now
researching the development of a low frequency radio system
to scan within arteries, producing 3D visuals, shown on a computer
screen, and used for intravenous navigation.
GBT/Tokenize
is evaluating
developing a system that will have the capability to
be manually remote controlled by physicians or to autonomously
operated inside blood vessels. It is intended that
an
advanced SOC (System on Chip) microchip with an embedded software
will control the unit's operations. The goal is to research
the
inclusion
of
a wireless
communication capability to produce a computerized 3D imaging for
the operating physician. We are evaluating
initial
setup of the system
for
inserted into a
human body, for example through a large leg artery, and
autonomously or manually travel further to other parts of the body.
Using a variety of micro-sensors,
we are
researching the viability of a system that will search and remove
clogs without damaging the vessel's tissue. The device
is intended
to use
an innovative AI controlled propulsion system that is based on
water jet propulsion concept that does not involve external,
rotating moving parts to avoid artery's walls damages. This
research is
looking into the viability of the use of the
most
recent micromachining
mechanical
engineering technology.
"Our AI
technology can be implemented in a wide variety of applications to
control mechanical, optical and electrical systems, analyzing
arterial data and making decisions in real time.
We are
commencing
research - code name Hermes, to use
our AI capabilities to search, identify and remove plaque within
arteries and blood vessels. In this
project, we are researching the
ability to use GBT
Tokenize's AI technology to control a
mini-probe unit that will be inserted into a human body through a
main artery. If our research is
positively concluded, we believe that this type of
system can be a breakthrough within the cardiovascular domain,
offering less invasive treatments and introducing a new method to
save lives. Artificial Intelligence technology encapsulates the
future health care and we're investing vast efforts to utilize our
experience and knowledge in this domain."
If the research of the
device is successfully concluded, the Company will be required to
obtain approval for use of the device from the US Food and Drug
Administration ("FDA"). Further, following the conclusion of
the research, the development of this product would require
significant funds as well as the partnering with a company that
specializes in the development of medical devices and obtaining FDA
approval.
About
Us
GBT
Technologies, Inc. (OTC
PINK: GTCH) ("GBT") (http://gbtti.com)
is a development stage company which considers itself a native of
Internet of Things (IoT), Artificial Intelligence (AI) and Enabled
Mobile Technology Platforms used to increase IC performance. GBT
has assembled a team with extensive technology expertise and is
building an intellectual property portfolio consisting of many
patents. GBT's mission, to license the technology and IP to
synergetic partners in the areas of hardware and software. Once
commercialized, it is GBT's goal to have a suite of products
including smart microchips, AI, encryption, Blockchain, IC design,
mobile security applications, database management protocols, with
tracking and supporting cloud software (without the need for GPS).
GBT envisions this system as a creation of a global mesh network
using advanced nodes and super performing new generation IC
technology. The core of the system will be its advanced microchip
technology; technology that can be installed in any mobile or fixed
device worldwide. GBT's vision is to produce this system as a low
cost, secure, private-mesh-network between any and all enabled
devices. Thus, providing shared processing, advanced mobile
database management and sharing while using these enhanced mobile
features as an alternative to traditional carrier
services.
Forward-Looking
Statements
Certain statements
contained in this press release may constitute "forward-looking
statements". Forward-looking statements
provide current expectations of future events based on certain
assumptions and include any statement that does not directly relate
to any historical or current fact. Actual results may differ
materially from those indicated by such forward-looking statements
as a result of various important factors as disclosed in our
filings with the Securities and Exchange Commission located at
their website ( http://www.sec.gov).
In addition to
these factors, actual future performance, outcomes, and results may
differ materially because of more general factors including
(without limitation) general industry and market conditions and
growth rates, economic conditions, governmental and public policy
changes, the Company's ability to raise capital on acceptable
terms, if at all, the Company's successful development of its
products and the integration into its existing products and the
commercial acceptance of the Company's products. The forward-looking
statements included in this press release represent the Company's
views as of the date of this press release and these views could
change. However, while the Company
may elect to update these forward-looking statements at some point
in the future, the Company specifically disclaims any obligation to
do so. These forward-looking
statements should not be relied upon as representing the Company's
views as of any date subsequent to the date of the press
release.
Contact:
Dr. Danny
Rittman, CTO
press@gopherprotocol.com